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Abstract—Accurate segmentation of lung and infection in
COVID-19 CT scans plays an important role in the quantitative
management of patients. Most of the existing studies are based
on large and private annotated datasets that are impractical to
obtain from a single institution, especially when radiologists are
busy fighting the coronavirus disease. Furthermore, it is hard
to compare current COVID-19 CT segmentation methods as
they are developed on different datasets, trained in different
settings, and evaluated with different metrics. In this paper,
we created a COVID-19 3D CT dataset with 20 cases that
contains 1800+ annotated slices and made it publicly available.
To promote the development of annotation-efficient deep learn-
ing methods, we built three benchmarks for lung and infec-
tion segmentation that contain current main research interests,
e.g., few-shot learning, domain generalization, and knowledge
transfer. For a fair comparison among different segmentation
methods, we also provide unified training, validation and testing
dataset splits, and evaluation metrics and corresponding code.
In addition, we provided more than 40 pre-trained baseline
models for the benchmarks, which not only serve as out-of-
the-box segmentation tools but also save computational time for
researchers who are interested in COVID-19 lung and infection
segmentation. To the best of our knowledge, this work presents
the largest public annotated COVID-19 CT volume dataset, the
first segmentation benchmark, and the most pre-trained models
up to now. We hope these resources (https://gitee.com/junma11/
COVID-19-CT-Seg-Benchmark) could advance the development
of deep learning methods for COVID-19 CT segmentation with
limited data.
Index Terms—COVID-19 CT, lung and infection segmentation,
few-shot learning, domain generalization, knowledge transfer
I. INTRODUCTION
COVID-19 (novel coronavirus 2019) has spread all overthe world during the past few months and caused over
170,000 deaths as of 23 April 2020[1]. It is projected to be a
seasonal disease after the current outbreak [2], [3].
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Computed tomography (CT) is playing an important role
in the fight against COVID-19 [4], [5], [6]. CT is shown
to be more sensitive in the early diagnosis of COIVD-
19 infection compared to Reverse Transcription-Polymerase
Chain Reaction (RT-PCR) tests [7]. Wang et al. trained a
deep learning model on 325 COVID-19 CT images and 740
typical pneumonia images. Their model identified 46 COVID-
19 cases that were previously missed by the RT-PCR test.
Further, quantitative information from CT images, such as lung
burden, percentage of high opacity and lung severity score, can
be used to monitor disease progression and help us understand
the course of COVID-19 [8], [9].
Artificial Intelligence (AI) methods, especially deep
learning-based methods, have been widely applied in medical
image analysis to combat COVID-19 [10]. For example, AI
can be used for building a contactless imaging workflow to
prevent transmission from patients to health care providers
[11]. In addition, most screening and segmentation algorithms
for COVID-19 are developed with deep learning models[7],
[12], [13], and most automatic diagnosis and infection quan-
tification systems in COVID-19 studies rely on segmentation
generated by deep neural networks[12], [14], [15], [16].
Although tremendous studies show that deep learning meth-
ods have potential for providing accurate and quantitative
assessment of COVID-19 infection in CT images [10], the
solutions mainly rely on large and private datasets. Due
to the patient privacy and intellectual property issues, the
datasets and solutions may not be publicly available. However,
researchers may hope that the datasets, entire source code and
trained models could be provided by authors [17].
Existing studies demonstrate that the classical U-Net (or
V-Net) can achieve promising segmentation performance if
hundreds of well-labelled training cases are available [15], [?].
83.1% to 91.6% of segmentation performance in Dice score
coefficient was reported in various U-Net-based approaches.
Shan et al. developed a neural network based on V-Net and
the bottle-neck structure to segment and quantify infection
regions [?], [18]. In their human-in-the-loop strategy, they
achieved 85.1%, 91.0% and 91.6% dice with 36, 114, and 249
labelled CT scans, respectively. Huang et al. [15] employed
U-Net [19] for lung and infection using an annotated dataset
of 774 cases, and demonstrated that trained model could be
used for quantifying the disease burden and monitoring disease
progression or treatment response. In general, we observed a
trend that training deep learning models with more annotations
will decrease the time needed for contouring the infection,
and increase segmentation accuracy, which is consistent with
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2the Shan et al.’s findings [?]. However, annotations for 3D
CT volume data are expensive to acquire because it not only
relies on professional diagnosis knowledge of radiologists, but
also takes much time and labor, especially in current situation.
Thus, a critical question would be:
how can we annotate COVID-19 CT scans efficiently?
Towards this question, three basic but important problems
remain unsolved:
• There is no publicly well-labelled COVID-19 CT 3D
dataset; Data collection is the first and essential step to
develop deep learning methods for COVID-19 segmen-
tation. Most of the existing studies rely on private and
large dataset with hundreds of annotated CT scans.
• There are no public benchmarks to evaluate differ-
ent deep learning-based solutions and different stud-
ies use various evaluation metrics. Similarly, datasets
for training, validating and testing are split diversely,
which also makes it hard for readers to com-
pare those methods. For example, although MedSeg
(http://medicalsegmentation.com/covid19/) dataset with
100 annotated slices were used in [20], [21], [22], [23] to
develop COVID-19 segmentation methods, it was split in
different ways and the developed methods were evaluated
by different metrics.
• There are no publicly available baseline models trained
for COVID-19. U-Net, a well-known segmentation archi-
tecture, is commonly used as a baseline network in many
studies. However, due to different implementations, the
reported performance variesin different studies [21], [24],
even though the experiments are conducted on the same
dataset.
In this paper, we focus on annotation-efficient deep learning
solutions and aim to alleviate the above problems by providing
a well-labelled COVID-19 CT dataset and a benchmark. In
particular, we first annotated left lung, right lung and infections
of 20 COVID-19 3D CT scans, and then established three tasks
to benchmark different deep learning strategies with limited
training cases. Finally, we built baselines for each task based
on U-Net.
Our tasks target on three popular research fields in medical
imaging community:
• Few-shot learning: building high performance models
from very few samples. Although most existing ap-
proaches focus on natural images, it has received growing
attention in medical imaging because generating labels
for medical images is much more difficult [25], [26].
• Domain generalization: learning from known domains
and applying to an unknown target domain that has
different data distribution [27]. Adversarial training is
usually adopted to achieve it in recent studies. [28], [29].
• Knowledge transfer: reusing existing annotations to boost
the training/fine-tuning on a new dataset. Transferring
knowledge from large public datasets is a well-established
practice in medical imaging analysis [30], [31]. Using
generative adversarial network to transfer knowledge
from publicly available annotated datasets to new datasets
for segmentation also receives significant attention [32],
[33].
Our contributions can be summarized as following:
• 20 well-labelled COVID-19 CT volume data are publicly
released to the community. To the best of our knowledge,
this is the largest public COVID-19 3D CT segmentation
datasets.
• 3 benchmark tasks are set up to promote studies
on annotation-efficient deep learning segmentation for
COVID-19 CT scans. Specifically, we focus on few-shot
learning, domain generalization, and knowledge transfer.
• 40+ trained models are publicly available that can serve
as baselines and out-of-the-box tools for COVID-19 CT
lung and infection segmentation.
II. DATASETS
Annotations of COVID-19 CT scans are scarce, but several
lung CT annotations with other diseases are publicly available.
Thus, one of the main goals for our benchmark is to explore
these existing annotations to assist COVID-19 CT segmenta-
tion. This section introduces the public datasets used in our
segmentation benchmarks. Figure 1 presents some examples
from each dataset.
A. Existing lung CT segmentation datasets
1) StructSeg lung organ segmentation: 50 lung cancer
patient CT scans are accessible, and all the cases are from
one medical center. This dataset served as a segmentation
challenge1 during MICCAI 2019. Six organs are annotated,
including left lung, right lung, spinal cord, esophagus, heart,
and trachea. In this paper, we only use the left lung and right
lung annotations.
2) NSCLC left and right lung segmentation: This dataset
consists of left and right thoracic volume segmentations de-
lineated on 402 CT scans from The Cancer Imaging Archive
NSCLC Radiomics [34], [35], [36].
B. Existing lung lesion CT segmentation datasets
1) MSD Lung tumor segmentation: This dataset is com-
prised of patients with non-small cell lung cancer from
Stanford University (Palo Alto, CA, USA) publicly avail-
able through TCIA. The dataset served as a segmentation
challenge2 during MICCAI 2018. The tumor is annotated by
an expert thoracic radiologist, and 63 labelled CT scans are
available.
2) StructSeg Gross Target Volume segmentation of lung
cancer: The same 50 lung cancer patient CT scans as the
above StructSeg lung organ segmentation dataset are provided,
and gross target volume of tumors are annotated in each case.
3) NSCLC Pleural Effusion (PE) segmentation: The CT
scans in this dataset are the same as those in NSCLC left
and right lung segmentation dataset, while pleural effusion is
delineated for 78 cases [34], [35], [36].
1MICCAI 2019 StructSeg: https://structseg2019.grand-challenge.org
2MICCAI 2018 MSD: http://medicaldecathlon.com/
3Fig. 1. Examples of four lung CT datasets. The 1st and 2nd row denote original CT images and corresponding ground truth of lung and lesions, respectively.
The 3rd row shows the 3D rendering results of ground truth. MSD Lung Tumor dataset (3rd column) does not provide lung masks.
C. Our COVID-19-CT-Seg dataset
We collected 20 public COVID-19 CT scans from the
Coronacases Initiative and Radiopaedia, which can be freely
downloaded3 with CC BY-NC-SA license. The left lung, right
lung, and infection were firstly delineated by junior annotators,
then refined by two radiologists with 5 years experience, and
finally all the annotations were verified and refined by a senior
radiologist with more than 10 years experience in chest radiol-
ogy. On average, it takes about 400± 45 minutes to delineate
one CT scan with 250 slices. We have made all the annotations
publicly available [37] at https://zenodo.org/record/3757476
with CC BY-NC-SA license.
III. BENCHMARK SETTINGS FOR COVID-19 CT LUNG
AND INFECTION SEGMENTATION
As mentioned in Section 1, there is a need for innovative
strategies that enable annotation-efficient methods for COVID-
CT segmentation. Thus, we set up three tasks to evaluate
potential annotation-efficient strategies. In particular, we focus
on learning to segment left lung, right lung and infection in
COVID-19 CT scans using
• pure but limited COVID-19 CT scans;
• existing annotated lung CT scans from other non-COVID-
19 lung diseases;
• heterogeneous datasets include both COVID-19 and non-
COVID-19 CT scans.
3https://github.com/ieee8023/covid-chestxray-dataset
A. Task 1: Learning with limited annotations
Task 1 is designed to address the problem of few-short
learning, where few annotations are available for training.
This task is based on the COVID-19-CT-Seg dataset only.
It contains three subtasks aiming to segment lung, infection
and both of them, respectively. For each subtask, 5-fold cross
validation results (based on a pre-defined dataset split file) are
reported. In each fold, 4 training cases are used for training
and the rest 16 cases are used for testing (Table I).
TABLE I
EXPERIMENTAL SETTINGS OF TASK 1 (LEARNING WITH LIMITED
ANNOTATIONS) FOR LUNG AND INFECTION SEGMENTATION IN COVID-19
CT SCANS. ALL THE EXPERIMENTS ARE BASE ON THE
COVID-19-CT-SEG DATASET.
Seg. Task Training and Testing
Lung 5-fold cross validation
4 cases (20% for training)
16 cases (80% for testing)
Infection
Lung and infection
B. Task 2: Learning to segment COVID-19 CT scans from
non-COVID-19 CT scans
Task 2 is designed to address the problem of domain
generalization, where only out-of-domain data are available for
training. Specifically, in the first subtask, the StructSeg Lung
dataset and the NSCLC Lung dataset are used for training a
lung segmentation model. In the second subtask, the MSD
Lung Tumor, the StructSeg Gross Target and the NSCLC
Pleural Effusion datasets are used. For both subtasks, 80% of
the data are randomly selected for training and the rest 20%
4are held-out for validation. All labelled COVID-CT-Seg CT
scans are kept for testing (Table II).
C. Task 3: Learning with both COVID-19 and non-COVID-19
CT scans
Task 3 is designed to address the problem of knowledge
transfer with heterogeneous annotations, where out-of-domain
data are used to boost the annotation-efficient training on
limited in-domain data. Specifically, in both subtasks (lung
segmentation and lung infection segmentation), 80% and 20%
of out-of-domain data are used for training and validation,
while 20% and 80% of in-domain data are used for training
and testing, respectively (Table III).
D. Evaluation metrics
Motivated by the evaluation methods of the well-known
medical image segmentation decathlon4, we also employ two
complementary metrics to evaluate the segmentation perfor-
mance. Dice similarity coefficient, a region-based measure,
is used to evaluate the region overlap. Normalized surface
Dice [38], a boundary-based measure is used to evaluate how
close the segmentation and ground truth surfaces are to each
other at a specified tolerance τ . For both two metrics, higher
scores admit better segmentation performance, and 100%
means perfect segmentation. Let G,S denote ground truth and
segmentation, respectively. We formulate the definitions of the
two measures as follows:
1) Region-based measure:
DSC(G,S) =
2|G ∩ S|
|G|+ |S| ;
2) Boundary-based measure:
NSD(G,S) =
|∂G ∩B(τ)∂S |+ |∂S ∩B(τ)∂G|
|∂G|+ |∂S|
where B(τ)∂G, B
(τ)
∂S ⊂ R3 denote the border region of ground
truth and segmentation surface at tolerance τ , which are
defined as B(τ)∂G = {x ∈ R3 | ∃x˜ ∈ ∂G, ||x − x˜|| ≤ τ} and
B
(τ)
∂S = {x ∈ R3 | ∃x˜ ∈ ∂S, ||x − x˜|| ≤ τ}, respectively.
We set tolerance τ as 1mm and 3mm for lung segmentation
and infection segmentation, respectively. The tolerance is
computed by measuring the inter-rater segmentation variation
between two different radiologists, which is also in accordance
with another independent study [38].
The main benefit of introducing Surface Dice is that it ig-
nores small boundary deviations because small inter-observer
errors are also unavoidable and often not clinically relevant
when segmenting the objects by radiologists.
E. U-Net baselines: oldies but goldies
U-Net ([19], [39]) has been proposed for 5 years, and many
variants have been proposed to improve it. However, recent
study [40] demonstrates that a basic U-Net is still difficult to
surpass if the corresponding pipeline is designed adequately.
4http://medicaldecathlon.com/files/MSD-Ranking-scheme.pdf
In particular, nnU-Net (no-new-U-Net) [40] was proposed
to automatically adapt preprocessing strategies and network
architectures (i.e., the number of pooling, convolutional kernel
size, and stride size) to a given 3D medical dataset. Without
manual tuning, nnU-Net achieved better performance than
most specialised deep learning pipelines in 19 public interna-
tional segmentation competitions and set a new state-of-the-
art in the majority of 49 tasks. The source code is publicly
available at https://github.com/MIC-DKFZ/nnUNet.
U-Net is often used as a baseline model in existing COVID-
19 CT segmentation studies. However, reported results vary a
lot even in the same dataset, which make it hard to compare
different studies. To standardize the U-Net performance, we
build our baselines on nnU-Net, which is the most powerful
U-Net implementation to the best of our knowledge. To make
it comparable between different tasks, we manually adjust the
patch size and network architectures in task 2 and task 3 to
be the same as task 1. Figure 2 shows details of the U-Net
architecture.
IV. RESULTS AND DISCUSSION
A. Results of Task 1: Learning with limited annotations
Table IV presents average DSC and NSD results of lung
and infection of each subtask in Task 1. It can be found that
• the average DSC and NSD values among different folds
vary greatly. It demonstrates that reporting 5-fold cross
validation results is necessary to obtain an object evalu-
ation because 1-fold results may be biased.
• promising results for left and right lung segmentation in
COVID-19 CT scans can be achieved with as few as
four training cases. Models trained for segmenting lung
obtained significantly better results compared with those
trained for segmenting lung and infection simultaneously.
• There is still large room for improving infection segmen-
tation with limited annotations. Statistical tests are needed
to justify whether there is an improvement from training
the model for segmenting lung and infection at the same
time.
B. Results of Task 2: Learning to segment COVID-19 CT scans
from non-COVID-19 CT scans
This task is quite challenging as the model does not see
any cases from target domain during training. In other words,
the trained models are expected to generalize to the unseen
domain (COVID-19 CT). Table V shows left lung and right
lung segmentation results in terms of average and standard
deviation values of DSC and NSD. It can be found that
• 3D U-Net achieves excellent performance in terms of
DSC on the validation set that is from the same source
domain. Average NSD values are lower than DSC values,
implying that most of the errors come from the boundary.
• the performance on the testing set drops significantly on
both subtasks. The performance of the model trained on
NSCLC Lung dataset is worse than the model trained on
StuctSeg lung. We suppose it is because the difference
in the distribution lung appearance is smaller between
StructSeg and COVID-19-CT.
5TABLE II
EXPERIMENTAL SETTINGS OF TASK 2 (LEARNING TO SEGMENT COVID-19 CT SCANS FROM NON-COVID-19 CT SCANS) FOR LUNG AND INFECTION
SEGMENTATION IN COVID-19 CT SCANS.
Seg. Task Training Validation (Unseen) Testing
Lung StructSeg Lung (40) StructSeg Lung (10) COVID-CT-SegLung (20)NSCLC Lung (322) NSCLC Lung (80)
Infection
MSD Lung Tumor (51) MSD Lung Tumor (12) COVID-CT-Seg
Infection (20)StructSeg Gross Target (40) StructSeg Gross Target (10)NSCLC Pleural Effusion (62) NSCLC Pleural Effusion (16)
TABLE III
EXPERIMENTAL SETTINGS OF TASK 3 (LEARNING WITH BOTH COVID-19 AND NON-COVID-19 CT SCANS) FOR LUNG AND INFECTION SEGMENTATION
IN COVID-19 CT SCANS.
Seg. Task Training Validation Testing
Lung StructSeg Lung (40) COVID-CT-SegLung (4)
StructSeg Lung (10) COVID-CT-Seg
Lung (16)NSCLC Lung (322) NSCLC Lung (80)
Infection
MSD Lung Tumor (51) COVID-CT-Seg
Infection (4)
MSD Lung Tumor (12) COVID-CT-Seg
Infection (16)StructSeg Gross Target (40) StructSeg Gross Target (10)NSCLC Pleural Effusion (62) NSCLC Pleural Effusion (16)
Fig. 2. Details of the 3D U-Net architecture that is used in this work.
Table VI shows quantitative infection segmentation results
in terms of average and standard deviation values of DSC and
NSD. It can be found that
• on the validation set, the performance of lesion segmen-
tation is not as good as the performance of lung segmen-
tation (Table V), which means that tumor segmentation
remains a challenging problem. This observation is in
line with recent results in MICCAI tumor segmentation
challenge, i.e. liver tumor segmentation [41] and kidney
tumor segmentation [42].
• The models almost fail to predict COVID-19 infections
on testing set, which highlights that the lesion appear-
ances differ significantly among lung cancer, pleural
effusion, and COVID-19 infections in CT scans.
C. Limitation
One possible limitation would be the number of cases in our
dataset is relatively small. On one hand, we focus on how to
learn from a few training cases(task 1) and how to efficiently
use existing annotations. Thus, the number of training cases
is acceptable for our benchmark tasks. On the other hand, we
have 16 or 20 testing cases in each task. The number of testing
cases is comparable with the setting of recent MICCAI 2020
segmentation challenges. For example, MyoPS 2020 (Myocar-
dial pathology segmentation combining multi-sequence CMR)
has 15 testing cases [43]. StructSeg (Automatic Structure
Segmentation for Radiotherapy Planning Challenge 2020) has
10 testing cases [44] and ASOCA (Automated Segmentation
6TABLE IV
QUANTITATIVE RESULTS OF 5-FOLD CROSS VALIDATION OF TASK 1: LEARNING WITH LIMITED ANNOTATIONS. FOR EACH FOLD, AVERAGE DSC AND
NSD VALUES ARE REPORTED. THE LAST ROW SHOWS THE AVERAGE RESULTS OF 80 (= 5 FOLDS ×16 TESTING CASES PER FOLD) TESTING CASES.
Subtask
Lung Infection Lung and InfectionLeft Lung Right Lung Left Lung Right Lung Infection
DSC NSD DSC NSD DSC NSD DSC NSD DSC NSD DSC NSD
Fold-0 84.98.2 68.713.3 85.213.0 70.615.8 68.120.5 70.921.3 53.828.4 39.118.3 65.519.4 47.414.3 65.423.9 068.223.2
Fold-1 80.314.5 61.815.1 83.99.6 68.39.0 71.320.5 71.823.0 40.318.7 27.512.0 60.111.1 41.79.9 64.721.8 60.625.1
Fold-2 87.112.1 74.316.0 90.38.2 78.512.0 66.221.7 71.724.2 80.318.8 66.818.8 85.212.4 68.615.1 60.727.6 62.528.9
Fold-3 88.47.0 75.28.8 89.96.3 78.58.0 68.123.1 70.827.1 79.713.6 65.414.4 84.09.8 67.713.0 62.027.9 65.328.9
Fold-4 88.376.0 75.811.0 90.27.0 78.310.2 62.726.9 64.928.2 72.421.1 58.620.8 80.913.4 63.415.9 51.430.2 51.931.0
Avg 85.810.5 71.213.8 87.99.3 74.811.9 67.322.3 70.024.4 65.425.6 51.622.9 75.316.8 57.917.5 60.826.3 61.627.5
TABLE V
QUANTITATIVE RESULTS (MEAN ± STANDARD DEVIATION) OF LUNG SEGMENTATION IN TASK 2.
Subtask
Validation Set (Unseen) Testing Set
Left Lung Right Lung Left Lung Right Lung
DSC NSD DSC NSD DSC NSD DSC NSD
StructSeg Lung 96.4 ± 1.4 74.6 ± 9.1 97.3 ± 0.3 74.3 ± 7.2 92.2 ± 19.7 82.0 ± 15.7 95.5 ± 7.2 84.2 ± 11.6
NSCLC Lung 95.3 ± 4.9 80.2 ± 8.3 95.4 ± 10.9 80.7 ± 10.7 57.5 ± 21.5 46.9 ± 16.9 72.2 ± 15.3 51.7 ± 16.8
TABLE VI
QUANTITATIVE RESULTS (MEAN ± STANDARD DEVIATION) OF INFECTION
SEGMENTATION IN TASK2.
Subtask Validation Set (Unseen) Testing SetDSC NSD DSC NSD
MSD Lung Tumor 67.2 ± 27.1 77.1 ± 31.4 25.2 ± 27.4 26.0 ± 28.5
StructSeg Tumor 71.3 ± 29.6 70.3 ± 29.5 6.0 ± 12.7 5.5 ± 10.7
NSCLC-PE 64.4 ± 45.5 73.7 ± 12.9 0.4 ± 0.8 3.7 ± 4.8
Of Coronary Arteries) has 20 testing cases [45].
Another possible limitation is that only quantitative results
of 3D U-Net are reported. We will also provide 2D U-Net
baselines for all tasks in the near future.
V. CONCLUSION
In this paper, we created a COVID-19 CT dataset,
established three segmentation benchmark tasks towards
annotation-efficient methods, and provided 40+ baselines mod-
els based on state-of-the-art segmentation architectures. All
the related results are publicly available at https://gitee.com/
junma11/COVID-19-CT-Seg-Benchmark. We hope this work
can help community to accelerate designing and developing
AI-based COVID-19 CT analysis tools with limited data.
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